4
Changes in Ownership
Entrada Therapeutics, Inc. Filed Acc 0001689375-24-000006
CEO gave up 7,604 shares (to pay taxes)
- CEO acquired 104,700 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Doshi Dipal CEO | 2024-03-01 | Grant or award | +104,700 | 347,979 | D | ||
| Doshi Dipal CEO | 2024-03-04 | Shares withheld for taxes | −1,164 | $12.42 | $14,460 | 346,815 | D |
| Doshi Dipal CEO | 2024-03-04 | Shares withheld for taxes | −1,391 | $13.37 | $18,594 | 345,424 | D |
| Doshi Dipal CEO | 2024-03-05 | Shares withheld for taxes | −5,049 | $12.28 | $61,996 | 340,375 | D |
| Derivatives | |||||||
| Doshi Dipal CEO | 2024-03-01 | Grant or award · Stock Option (Right to Buy) | +158,500 | 158,500 | D | ||
Loading xslF345X05/wk-form4_1709686121.xml…